Ethanol (EtOH)-induced behavioral sensitization (EIBS) is proposed to play a role in early and recurring steps of alcohol dependence, but its impact on alcohol abuse is not clear. EIBS development is dependent upon animal species, strain and also individual factors. We proposed here to decipher the co-expression of EIBS and EtOH intake in individual animals among outbred Swiss mice, which exhibit heterogeneity that parallels what may occur in humans. To do so, mice were exposed to a two-bottle choice with free access to water or 10% EtOH for 6 days just before and immediately after chronic intraperitoneal 2.5 g/kg ethanol injections once a day for 10 consecutive days. Based on their sensitization scores, mice were split into resistant and sensitized animals. First, we showed that individual susceptibility to EIBS is inversely correlated with voluntary EtOH consumption. Exposure to repeated EtOH during EIBS development increased subsequent EtOH intake among the entire population. Very interestingly, subsequent analyses suggested that the less the mice are sensitized the more they increase their EtOH intake; however, resistant mice were sensitive to EtOH adulteration with quinine, whereas sensitized ones maintained their EtOH intake levels, therefore exhibiting a compulsive-like drinking pattern. In addition, we showed that resistant mice do not exhibit a weaker sensitivity to the aversive properties of EtOH that may contribute to their higher level of EtOH intake compared to sensitized mice. This study confirms and extends previous data showing a deep relationship between propensity for EtOH consumption and susceptibility to EIBS in Swiss mice.

Download full-text PDF

Source
http://dx.doi.org/10.1111/adb.12104DOI Listing

Publication Analysis

Top Keywords

etoh intake
20
etoh
11
mice
9
behavioral sensitization
8
eibs development
8
swiss mice
8
mice exhibit
8
susceptibility eibs
8
etoh consumption
8
resistant mice
8

Similar Publications

Background & Aims: Expression of P21, encoded by the gene, has been associated with fibrosis progression in steatotic liver disease (SLD); however, the underlying mechanisms remain unknown. In the present study, we investigated the function of CDKN1A in SLD.

Methods: expression levels were evaluated in different patient cohorts with SLD, fibrosis, and advanced chronic liver disease (ACLD).

View Article and Find Full Text PDF

Oleanolic acid protects ethanol-induced memory impairments.

Behav Brain Res

March 2025

Department of Korean Internal Medicine, College of Korean Medicine, Sang-Ji University, 3 Sangjidae-gil, Wonju-si, Gangwon-do 26339, Republic of Korea. Electronic address:

Article Synopsis
  • * Ethanol affects GABA receptors, leading to changes in neurotransmission that could result in memory loss and increase the likelihood of psychiatric disorders like dementia.
  • * Oleanolic acid (OA) was found to protect against ethanol-induced memory impairment by blocking alterations in N-methyl-D-aspartate receptor function, suggesting its potential as a treatment for overcoming Ethanol-related cognitive issues.
View Article and Find Full Text PDF

Chronic alcohol-related myopathy: a closer look at the role of lipids.

Front Physiol

November 2024

Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, United States.

Article Synopsis
  • Chronic alcohol-related myopathy (CAM) is a condition that results in muscle weakness and atrophy due to long-term excessive alcohol consumption.
  • The mechanisms behind how alcohol causes muscle loss are not fully understood, but this article explores how changes in lipid profiles may play a significant role.
  • The authors review existing studies on lipid changes in individuals with CAM and suggest that disrupted lipid regulation could be a key factor in the muscle wasting linked to alcohol use, proposing new directions for research and treatment.
View Article and Find Full Text PDF

Objective: To examine the efficacy and safety of sodium oxybate versus placebo in a phase IIb randomized double-blind placebo-controlled 2-period cross-over clinical trial in patients with isolated laryngeal dystonia (LD).

Methods: The study was conducted from January 2018 to December 2021, pausing during the COVID-19 pandemic, at Massachusetts Eye and Ear in 106 patients with alcohol-responsive (EtOH+) and alcohol-non-responsive (EtOH-) LD (53 to receive 1.5g of sodium oxybate first, 53 to receive matching placebo first).

View Article and Find Full Text PDF

Genome wide association and animal studies have implicated genetic variations in CHRNΑ5, encoding the α5 subunit-containing nicotinic acetylcholine receptors (α5*nAChRs), as a risk factor for developing alcohol use disorders (AUDs). To understand how α5*nAChR mutations may influence alcohol (EtOH) drinking behavior, we used a two-bottle choice procedure with intermittent access to alcohol in male and female transgenic mice expressing either the highly frequent human single nucleotide polymorphism (α5SNP/rs16969968) or a deletion of the Chrna5 gene (α5KO). AUDs-related preconsommatory traits (anxiety, sensation-seeking and impulsivity) were assessed with a battery of relevant tasks (elevated-plus maze, novel place preference and step-down inhibitory avoidance).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!